[1]BeilsteinJournalofOrganicChemistry,2018,vol.14,p.122-1228
[2]MedChemComm,2016,vol.7,p.1022-1032
[3]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.5689-5692
[1]Patent:WO2018/69222,2018,A1.Locationinpatent:Page/Pagecolumn160
126417-81-0
1572-10-7
766519-89-5
827-41-8
151293-15-1
397844-80-3
667437-08-3 | 4-Allyl-5-[(4-fluorophenoxy)methyl]-4h-1,2,4-triazole-3-thiol | AA00FAKC | MFCD03900637
66090-36-6 | 3-CHLOROBENZOYL ISOTHIOCYANATE | AA00FAR1 | MFCD00041103
6850-60-8 | 4-Ethoxybenzylamine | AA00FAYI | MFCD02225920
69807-81-4 | (1-Methyl-1h-pyrrol-2-yl)methylamine | AA00FB6P | MFCD02677708
667463-62-9 | BIO | AA00FBFK | MFCD08705318
70766-71-1 | 2-BROMOPYRIDINE-D4 | AA00FBMH | MFCD06658667
66346-53-0 | 5-Hydroxy-7-methyl-4-propyl-2h-chromen-2-one | AA00FBRE | MFCD02080283
737789-87-6 | Relugolix | AA00FBYA | MFCD25976856
65754-04-3 | 6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid | AA00FC2Q | MFCD08692965
676527-73-4 | 4-[(4-Methylphenyl)sulfonyl]piperidine hydrochloride | AA00FCA1 | MFCD04039168